Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma

NCT01974284 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT01974284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01974284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2014
Completion date
June 29, 2017
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

papillary thyroid cancer